{
    "clinical_study": {
        "@rank": "26993", 
        "arm_group": [
            {
                "arm_group_label": "EARLY # CNS RELAPSE with BM DONOR", 
                "arm_group_type": "Experimental", 
                "description": "Induction (Etoposide, Ifosfamide with Mesna Uroprotection,Ifosfamide, Dexamethasone, Vincristine sulfate, PEG, ITT (methotrexate, cytosine arabinoside and therapeutic hydrocortisone), and leucovorin calcium then Intensification (4 courses of 6 weeks, ITT, dexamethasone, vincristine, methotrexate, leucovorin, 6-Thioguanine, cytarabine (Ara-C), Etoposide, pegaspargase, Ifosfamide with Mesna) and Idarubicin and CXRT."
            }, 
            {
                "arm_group_label": "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR", 
                "arm_group_type": "Experimental", 
                "description": "Induction (Etoposide, Ifosfamide with Mesna Uroprotection,Ifosfamide, Dexamethasone, Vincristine sulfate, pegaspargase, ITT (methotrexate, cytosine arabinoside and therapeutic hydrocortisone), and leucovorin calcium then Intensification (4 courses of 6 weeks, ITT, dexamethasone, vincristine, methotrexate, leucovorin, 6-Thioguanine, cytarabine (Ara-C), Etoposide, PEG, Ifosfamide with Mesna) and Idarubicin), and Maintenance (4 x 12 courses) of ITT, Vincristine, Methotrexate, T-thioguanine."
            }
        ], 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing\n      so they stop growing or die.\n\n      PURPOSE: Phase III trial to compare the effectiveness of combination chemotherapy in\n      treating children who have relapsed acute lymphoblastic leukemia."
        }, 
        "brief_title": "Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia", 
        "completion_date": {
            "#text": "April 2006", 
            "@type": "Actual"
        }, 
        "condition": "Leukemia", 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Lymphoid", 
                "Precursor Cell Lymphoblastic Leukemia-Lymphoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Improve the outcome in children with first isolated central nervous system\n      (CNS), testicular, or ocular relapse of acute lymphoblastic lymphoma (ALL), and increase the\n      knowledge of the characteristics of extramedullary and subsequent relapses of ALL. II.\n      Quantitate, by current molecular biologic techniques, occult systemic leukemia in cases of\n      conventional isolated extramedullary relapse, and examine the relationship between this\n      assessment and subsequent clinical outcome, particularly overt marrow relapse. III.\n      Quantitate occult systemic leukemia in subsets of extramedullary relapse that include site\n      (CNS, testis, or eye), time of relapse (early or late), initial risk group, immunophenotype,\n      DNA index and karyotype, gender (for CNS and eye), and ethnicity, and assess the response to\n      therapy in patients entered on companion protocol CCG-B958. IV. Compare the relative\n      sensitivities of two quantitative in vitro assays for occult systemic leukemia\n      (fluorescence-activated cell sorter/leukemic progenitor cell clonogenic assay vs. polymerase\n      chain reaction-based clonospecific assay), correlate the assays with clinical outcome, and\n      assess other biologic studies of leukemic cells (e.g., neurotropic potential in the SCID\n      mouse xenograft model and methotrexate sensitivity). V. Determine the event-free survival\n      (EFS) and pattern of failure in children with first isolated CNS, testicular, or ocular\n      relapse after treatment that includes intensive systemic chemotherapy. VI. Correlate EFS in\n      patients with CNS and ocular relapse with sex, and in patients with relapse at all three\n      sites with ethnicity. VII. Evaluate the impact of combined chemotherapy and radiotherapy on\n      health status in survivors at two and four years after extramedullary relapse and study\n      entry.\n\n      OUTLINE: All patients receive induction chemotherapy over 5 weeks with: etoposide,\n      ifosfamide/mesna, dexamethasone, vincristine, and pegaspargase (if pegaspargase is not\n      available, E. coli asparaginase may be substituted throughout study); then dexamethasone,\n      vincristine, pegaspargase (or E. coli asparaginase), and high-dose methotrexate with\n      leucovorin rescue; and triple intrathecal chemotherapy (TIT). Following induction\n      chemotherapy, all patients receive two 6-week courses of intensification therapy with\n      intermittent TIT; each course consists of dexamethasone, vincristine, high-dose\n      methotrexate/leucovorin, thioguanine, cytarabine, etoposide, and pegaspargase (or E. coli\n      asparaginase) followed by dexamethasone, vincristine, high-dose methotrexate/leucovorin,\n      thioguanine, ifosfamide/mesna, and idarubicin. Patients receive 2 additional courses of\n      intensification chemotherapy followed by four 12-week courses of maintenance chemotherapy\n      with vincristine and methotrexate every 2 weeks and daily oral thioguanine. Total duration\n      of therapy is 78 weeks. Patients with isolated ocular relapse receive local radiotherapy\n      prior to initiation of induction chemotherapy; those who also have CNS leukemia begin TIT\n      with the radiotherapy. Patients with CNS relapse receive craniospinal irradiation during the\n      first month of maintenance therapy, with the dose and fields based on whether they will\n      receive TBI and whether they have had CNS irradiation previously. Patients with testicular\n      relapse receive bilateral testicular irradiation during the first 3 weeks of intensification\n      therapy. Patients are followed every 3 months for 3 years, every 6 months for 3 years, and\n      yearly thereafter, or upon relapse, second malignancy, loss to follow up, or death. All\n      patients undergo quality-of-life assessment at entry and 2 and 4 years after entry.\n\n      PROJECTED ACCRUAL: Approximately 120 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Acute lymphoblastic leukemia (ALL) with isolated extramedullary\n        relapse Relapse occurred during or following front-line therapy for ALL Initial diagnosis\n        of more than 25% blasts of L1 or L2 morphology No leukemic marrow (M1) by conventional\n        assessment Patients with B precursor ALL must also be enrolled on study CCG-B958 Relapse\n        occurred in the CNS, testis, or eye Ocular relapse confirmed by an ophthalmologist and by\n        cytology or iris biopsy Combined CNS and ocular relapse eligible Down Syndrome patients\n        not eligible No prior bone marrow transplantation in first remission No prior toxicity\n        from any study drugs Patient age: Under 21\n\n        PATIENT CHARACTERISTICS: See General Eligibility Criteria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "20 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002816", 
            "org_study_id": "1951", 
            "secondary_id": [
                "CCG-1951", 
                "CDR0000064968"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "description": "Given IV", 
                "intervention_name": "cytarabine", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Cytosine Arabinoside", 
                    "Ara-C", 
                    "Cytarabine", 
                    "Cytosar-U", 
                    "NSC-63878"
                ]
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "description": "Given IV", 
                "intervention_name": "dexamethasone", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Decadron", 
                    "NSC- 34521"
                ]
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "description": "Given IV", 
                "intervention_name": "etoposide", 
                "intervention_type": "Drug", 
                "other_name": [
                    "VP-16", 
                    "VePesid", 
                    "NSC-14154p"
                ]
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "description": "Given IV", 
                "intervention_name": "idarubicin", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Idamycin", 
                    "NSC-256439"
                ]
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "description": "Given IV", 
                "intervention_name": "ifosfamide", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Ifex", 
                    "NSC-109724"
                ]
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "intervention_name": "leucovorin calcium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "description": "Given IV", 
                "intervention_name": "mesna", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Mesnex", 
                    "NSC-113891"
                ]
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "description": "Given IV", 
                "intervention_name": "pegaspargase", 
                "intervention_type": "Drug", 
                "other_name": [
                    "PEG Asparaginase", 
                    "PEG-ASP", 
                    "K/H", 
                    "KYOWA", 
                    "HAKKO", 
                    "NSC-644954"
                ]
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "intervention_name": "therapeutic hydrocortisone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "intervention_name": "thioguanine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "description": "Given IV", 
                "intervention_name": "vincristine sulfate", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Oncovin", 
                    "NSC-675574"
                ]
            }, 
            {
                "arm_group_label": "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR", 
                "intervention_name": "low-LET cobalt-60 gamma ray therapy", 
                "intervention_type": "Radiation"
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "intervention_name": "low-LET electron therapy", 
                "intervention_type": "Radiation"
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "intervention_name": "low-LET photon therapy", 
                "intervention_type": "Radiation"
            }, 
            {
                "arm_group_label": [
                    "EARLY # CNS RELAPSE with BM DONOR", 
                    "LATE CNS RELAPSE with/without BM DONOR, TESTICULAR or OCULAR"
                ], 
                "description": "Given IV", 
                "intervention_name": "Methotrexate", 
                "intervention_type": "Drug", 
                "other_name": [
                    "MTX", 
                    "NSC-740"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Mesna", 
                "Levoleucovorin", 
                "Etoposide phosphate", 
                "Isophosphamide mustard", 
                "Pegaspargase", 
                "Asparaginase", 
                "Cytarabine", 
                "Dexamethasone", 
                "Etoposide", 
                "Idarubicin", 
                "Ifosfamide", 
                "Methotrexate", 
                "Thioguanine", 
                "Vincristine", 
                "Dexamethasone acetate", 
                "Cortisol succinate", 
                "Hydrocortisone acetate", 
                "Hydrocortisone 17-butyrate 21-propionate", 
                "Hydrocortisone", 
                "Dexamethasone 21-phosphate", 
                "BB 1101", 
                "Hydrocortisone-17-butyrate", 
                "Leucovorin"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "keyword": "recurrent childhood acute lymphoblastic leukemia", 
        "lastchanged_date": "August 21, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/CCG-1951"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Long Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90806"
                    }, 
                    "name": "Long Beach Memorial Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90027-0700"
                    }, 
                    "name": "Children's Hospital Los Angeles"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095-1781"
                    }, 
                    "name": "Jonsson Comprehensive Cancer Center, UCLA"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92668"
                    }, 
                    "name": "Children's Hospital of Orange County"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94115-0128"
                    }, 
                    "name": "UCSF Cancer Center and Cancer Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80218"
                    }, 
                    "name": "Children's Hospital of Denver"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20010-2970"
                    }, 
                    "name": "Children's National Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60637"
                    }, 
                    "name": "University of Chicago Cancer Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202-5265"
                    }, 
                    "name": "Indiana University Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iowa City", 
                        "country": "United States", 
                        "state": "Iowa", 
                        "zip": "52242"
                    }, 
                    "name": "University of Iowa Hospitals and Clinics"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48109-0752"
                    }, 
                    "name": "University of Michigan Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55455"
                    }, 
                    "name": "University of Minnesota Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55905"
                    }, 
                    "name": "Mayo Clinic Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "64108"
                    }, 
                    "name": "Children's Mercy Hospital - Kansas City"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68198-3330"
                    }, 
                    "name": "University of Nebraska Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Herbert Irving Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "Kaplan Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Memorial Sloan-Kettering Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27599-7295"
                    }, 
                    "name": "Lineberger Comprehensive Cancer Center, UNC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45229-3039"
                    }, 
                    "name": "Children's Hospital Medical Center - Cincinnati"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44106-5065"
                    }, 
                    "name": "Ireland Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43205-2696"
                    }, 
                    "name": "Children's Hospital of Columbus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97201-3098"
                    }, 
                    "name": "Doernbecher Children's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Children's Hospital of Philadelphia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15213"
                    }, 
                    "name": "Children's Hospital of Pittsburgh"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37232-6838"
                    }, 
                    "name": "Vanderbilt Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84132"
                    }, 
                    "name": "Huntsman Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98105"
                    }, 
                    "name": "Children's Hospital and Regional Medical Center - Seattle"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98109"
                    }, 
                    "name": "Fred Hutchinson Cancer Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madison", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53792"
                    }, 
                    "name": "University of Wisconsin Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Perth", 
                        "country": "Australia", 
                        "state": "Western Australia", 
                        "zip": "6001"
                    }, 
                    "name": "Princess Margaret Hospital for Children"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "state": "British Columbia", 
                        "zip": "V6H 3V4"
                    }, 
                    "name": "British Columbia Children's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Halifax", 
                        "country": "Canada", 
                        "state": "Nova Scotia", 
                        "zip": "B3J 3G9"
                    }, 
                    "name": "IWK Grace Health Centre"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia", 
                "Canada"
            ]
        }, 
        "official_title": "EXTRAMEDULLARY RELAPSE AND OCCULT BONE MARROW INVOLVEMENT IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE III GROUP-WIDE STUDY", 
        "overall_official": {
            "affiliation": "Princess Margaret Hospital for Children", 
            "last_name": "Michael L.N. Willoughby, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2002", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The evaluation of the relationship between prognostic or treatment factors and EFS", 
            "measure": "Event Free Survival", 
            "safety_issue": "Yes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002816"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "11426549", 
                "citation": "Uckun FM, Gaynon PS, Stram DO, Sensel MG, Sarquis MB, Willoughby M. Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse. Leuk Lymphoma. 2001 Jan;40(3-4):279-85."
            }, 
            {
                "PMID": "10499612", 
                "citation": "Uckun FM, Gaynon PS, Stram DO, Sensel MG, Sarquis MB, Lazarus KH, Willoughby M. Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse. Clin Cancer Res. 1999 Sep;5(9):2415-20."
            }
        ], 
        "source": "Children's Oncology Group", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Children's Oncology Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 1996", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }, 
    "geocoordinates": {
        "British Columbia Children's Hospital": "49.261 -123.114", 
        "Children's Hospital Los Angeles": "34.052 -118.244", 
        "Children's Hospital Medical Center - Cincinnati": "39.103 -84.512", 
        "Children's Hospital and Regional Medical Center - Seattle": "47.606 -122.332", 
        "Children's Hospital of Columbus": "39.961 -82.999", 
        "Children's Hospital of Denver": "39.739 -104.985", 
        "Children's Hospital of Orange County": "33.788 -117.853", 
        "Children's Hospital of Philadelphia": "39.952 -75.164", 
        "Children's Hospital of Pittsburgh": "40.441 -79.996", 
        "Children's Mercy Hospital - Kansas City": "39.1 -94.579", 
        "Children's National Medical Center": "38.895 -77.036", 
        "Doernbecher Children's Hospital": "45.523 -122.676", 
        "Fred Hutchinson Cancer Research Center": "47.606 -122.332", 
        "Herbert Irving Comprehensive Cancer Center": "40.714 -74.006", 
        "Huntsman Cancer Institute": "40.761 -111.891", 
        "IWK Grace Health Centre": "44.649 -63.575", 
        "Indiana University Cancer Center": "39.769 -86.158", 
        "Ireland Cancer Center": "41.499 -81.695", 
        "Jonsson Comprehensive Cancer Center, UCLA": "34.052 -118.244", 
        "Kaplan Cancer Center": "40.714 -74.006", 
        "Lineberger Comprehensive Cancer Center, UNC": "35.913 -79.056", 
        "Long Beach Memorial Medical Center": "33.804 -118.158", 
        "Mayo Clinic Cancer Center": "44.022 -92.47", 
        "Memorial Sloan-Kettering Cancer Center": "40.714 -74.006", 
        "Princess Margaret Hospital for Children": "-31.953 115.857", 
        "UCSF Cancer Center and Cancer Research Institute": "37.775 -122.419", 
        "University of Chicago Cancer Research Center": "41.878 -87.63", 
        "University of Iowa Hospitals and Clinics": "41.661 -91.53", 
        "University of Michigan Comprehensive Cancer Center": "42.281 -83.743", 
        "University of Minnesota Cancer Center": "44.98 -93.264", 
        "University of Nebraska Medical Center": "41.252 -95.998", 
        "University of Wisconsin Comprehensive Cancer Center": "43.073 -89.401", 
        "Vanderbilt Cancer Center": "36.166 -86.784"
    }
}